Skip to main content
Clinical Trials/NCT07140731
NCT07140731RecruitingNot Applicable

An Early Feasibility Study for the Symani Surgical System

Jacobs institute2 sites in 1 country15 target enrollmentStarted: September 20, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
15
Locations
2
Primary Endpoint
CT Imaging

Study Overview

Brief Summary

A research study for a neurosurgical procedure in adult patients with Moyamoya disease

Detailed Description

The purpose of this research is to assess the safety and effectiveness of the Symani Surgical System in adult patients with Moyamoya disease.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients aged >
  • Moyamoya disease with minor to moderate symptoms requiring neurosurgical treatment.
  • Patients agree to have the surgery and the anesthesia.
  • Patients who voluntarily decide to participate in this study with the surgery performed with the aid of Symani and agree to sign the Informed Consent Form.

Exclusion Criteria

  • Patients who have bleeding or coagulation disorders in the past or present.
  • Any criteria that preclude prolonged anesthesia.
  • Hemodynamically unstable neurological exam.
  • Pressure dependent neurologic status.

Outcomes

Primary Outcomes

CT Imaging

Time Frame: 6 Months

Stable cerebral perfusion confirmed with CT Imaging

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Jacobs institute
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Adnan Siddiqui

Principal Investigator

Jacobs institute

Study Sites (2)

Loading locations...

Similar Trials